Suchergebnisse - %22Adalimumab%22

PubPharm (40)

31

"In vitro" azathioprine-induced changes in peripheral T cell apoptosis and IFN-γ production associate with drug response in patients with Crohn's Disease

enthalten in: Journal of Crohn's & colitis | 2013

von Cossu, A. | Biancone, L. | Ascolani, M. | +2

CommentIn: J Crohns Colitis. 2013 Nov;7(10):e497-8. - PMID 23685139

32

Anti-TNF antibodies do not induce the apoptosis of lamina propria mononuclear cells in uninflamed intestinal tissue in patients with Crohn's disease

enthalten in: Folia histochemica et cytobiologica | 2013

von Eder, P. | Lykowska-Szuber, L. | Krela-Kazmierczak, I. | +6

33

Randomized controlled trials in maintenance of remission in Crohn's disease

enthalten in: Reviews on recent clinical trials | 2012

von D'Incà, R. | Caccaro, R.

34

Adalimumab in budesonide and methotrexate refractory collagenous colitis

enthalten in: Scandinavian journal of gastroenterology | 2012

von Münch, A. | Ignatova, S. | Ström, M.

35

Anti-tumor necrosis factor-α antibodies induce regulatory macrophages in an Fc region-dependent manner

enthalten in: Gastroenterology | 2011

von Vos, A. | Wildenberg, M. | Duijvestein, M. | +3

36

Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease

enthalten in: The American journal of gastroenterology | 2009

von Marehbian, J. | Arrighi, H. | Hass, S. | +2

CommentIn: Inflamm Bowel Dis. 2010 Aug;16(8):1443-4. - PMID 19834975

37

Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis : effect of TNFalpha antagonist therapy

enthalten in: Joint bone spine | 2008

von Wendling, D. | Cedoz, J. | Racadot, E.

38

Caspase activation and apoptosis induction by adalimumab : demonstration in vitro and in vivo in a chimeric mouse model

enthalten in: Inflammatory bowel diseases | 2006

von Shen, C. | Van Assche, G. | Rutgeerts, P. | +1

39

New drugs 04, part 1

enthalten in: Nursing | 2004

von Hussar, D.

40

How future tumor necrosis factor antagonists and other compounds will meet the remaining challenges in Crohn's disease

enthalten in: Reviews in gastroenterological disorders | 2004

von Sandborn, W.